Suppliers / Aurobindo Pharma Limited, Unit - VIII

Aurobindo Pharma Limited, Unit - VIII

Saudi Arabia Updated 9 July 2026

Aurobindo Pharma Limited, Unit - VIII is an API manufacturer based in Saudi Arabia.

0
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Amlodipine SFDA (Saudi Arabia) 1
Bosentan SFDA (Saudi Arabia) 1
Carvedilol SFDA (Saudi Arabia) 1
Dutasteride SFDA (Saudi Arabia) 1
Febuxostat SFDA (Saudi Arabia) 1
Fluconazole SFDA (Saudi Arabia) 1
Moxifloxacin SFDA (Saudi Arabia) 1
Palonosetron SFDA (Saudi Arabia) 1
Ramipril SFDA (Saudi Arabia) 1
Tamsulosin SFDA (Saudi Arabia) 1
Show all 11 molecules on file
Torasemide SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Dutasteride API Fluconazole API Ramipril API Amlodipine API Tamsulosin API Carvedilol API Febuxostat API Moxifloxacin API

Comparing suppliers?

Choose your molecules and target markets. Aurobindo Pharma Limited, Unit - VIII comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability